[go: up one dir, main page]

NO20090392L - Penem promedikamenter - Google Patents

Penem promedikamenter

Info

Publication number
NO20090392L
NO20090392L NO20090392A NO20090392A NO20090392L NO 20090392 L NO20090392 L NO 20090392L NO 20090392 A NO20090392 A NO 20090392A NO 20090392 A NO20090392 A NO 20090392A NO 20090392 L NO20090392 L NO 20090392L
Authority
NO
Norway
Prior art keywords
penem
promotions
sulopenem
solvates
hydrates
Prior art date
Application number
NO20090392A
Other languages
English (en)
Inventor
Anthony Marfat
Dale Gordon Mcleod
Katherine Elizabeth Brighty
John Paul O'donnell
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO20090392L publication Critical patent/NO20090392L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/88—Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D499/887—Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with a hetero atom or a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A61K31/431—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems containing further heterocyclic rings, e.g. ticarcillin, azlocillin, oxacillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

Det beskrives oralt tilgjengelige prodrugs av sulopenem, feks. forbindelse (I) og solvater og hydrater samt preparater og formuleringer derav. Videre beskrives anvendelsen for å behandle og å forhindre infeksjon i pattedyr som mennesker.
NO20090392A 2006-06-28 2009-01-27 Penem promedikamenter NO20090392L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US80600006P 2006-06-28 2006-06-28
US91158707P 2007-04-13 2007-04-13
PCT/IB2007/001843 WO2008001212A2 (en) 2006-06-28 2007-06-18 Penem prodrugs

Publications (1)

Publication Number Publication Date
NO20090392L true NO20090392L (no) 2009-01-27

Family

ID=38463109

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20090392A NO20090392L (no) 2006-06-28 2009-01-27 Penem promedikamenter

Country Status (28)

Country Link
US (2) US7795243B2 (no)
EP (1) EP2044085B1 (no)
JP (2) JP4397435B2 (no)
KR (1) KR101060448B1 (no)
AP (1) AP2008004705A0 (no)
AR (1) AR061646A1 (no)
AT (1) ATE493419T1 (no)
AU (1) AU2007263519B2 (no)
BR (1) BRPI0712740A2 (no)
CA (1) CA2655485C (no)
CL (1) CL2007001910A1 (no)
CR (1) CR10467A (no)
DE (1) DE602007011622D1 (no)
DK (1) DK2044085T3 (no)
EA (1) EA200870584A1 (no)
EC (1) ECSP088947A (no)
GT (1) GT200700050A (no)
IL (1) IL195383A0 (no)
MA (1) MA30568B1 (no)
MX (1) MX2009000116A (no)
NL (1) NL2000715C2 (no)
NO (1) NO20090392L (no)
PE (1) PE20080940A1 (no)
SV (1) SV2008003139A (no)
TN (1) TNSN08537A1 (no)
TW (1) TW200816999A (no)
UY (1) UY30439A1 (no)
WO (1) WO2008001212A2 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20080940A1 (es) * 2006-06-28 2008-07-09 Pfizer Prod Inc Profarmacos de penem
US20080125408A1 (en) * 2006-11-14 2008-05-29 Pfizer Inc Penem prodrug
WO2009108704A1 (en) * 2008-02-25 2009-09-03 Semafore Pharmaceuticals, Inc. O-alkylated pi-3 kinase inhibitor prodrug combination
KR100916052B1 (ko) 2009-02-24 2009-09-08 코오롱건설주식회사 진공이송 쓰레기 수거시스템의 쓰레기 배출밸브
CA2768877A1 (en) * 2009-08-10 2011-02-17 Bellus Health Inc. Methods, compounds, and compositions for delivering 1,3-propanedisulfonic acid
US11554112B2 (en) * 2018-06-07 2023-01-17 Herum Therapeutics International Limited Combinations of β-lactam compounds and probenecid and uses thereof
EA202192193A1 (ru) * 2019-02-13 2021-11-09 Итерум Терапьютикс Интернэшнл Лимитед Комбинации бета-лактамных соединений и пробенецида и их применения

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4619924A (en) 1984-05-18 1986-10-28 Pfizer Inc. 2-alkylthiopenem derivatives
US4870170A (en) * 1985-10-17 1989-09-26 Pfizer Inc. Process for 2-(1-oxo-3-thiolanyl)-2-penem antibiotics
WO1988008845A1 (en) * 1987-05-11 1988-11-17 Pfizer Inc. Diastereomeric 5r,6s-6-(1r-hydroxyethyl)-2-(cis-1-oxo-3-thiolanylthio)-2-penem-3-carboxylic acids
GB8713515D0 (en) * 1987-06-10 1987-07-15 Erba Farmitalia Methoxymethyl compounds
US4874877A (en) * 1988-04-19 1989-10-17 Pfizer Inc. Process for optically active 3-(methane-sulfonyloxy)thiolane and analogs
JP3148236B2 (ja) * 1990-08-20 2001-03-19 サントリー株式会社 ペネム化合物
ES2123512T3 (es) * 1990-08-20 1999-01-16 Suntory Ltd Compuestos de penem antibacterianos.
WO2004067532A1 (ja) 2003-01-31 2004-08-12 Meiji Seika Kaisha, Ltd. 新規カルバペネム誘導体
PE20080940A1 (es) * 2006-06-28 2008-07-09 Pfizer Prod Inc Profarmacos de penem
EP2043728A2 (en) * 2006-07-11 2009-04-08 Microchips, Inc. Multi-reservoir pump device for dialysis, biosensing, or delivery of substances
US20080125408A1 (en) * 2006-11-14 2008-05-29 Pfizer Inc Penem prodrug

Also Published As

Publication number Publication date
GT200700050A (es) 2008-02-01
US20080009474A1 (en) 2008-01-10
MA30568B1 (fr) 2009-07-01
TW200816999A (en) 2008-04-16
CA2655485A1 (en) 2008-01-03
AP2008004705A0 (en) 2008-12-31
ATE493419T1 (de) 2011-01-15
UY30439A1 (es) 2008-01-31
ECSP088947A (es) 2009-01-30
NL2000715C2 (nl) 2008-03-11
HK1134928A1 (en) 2010-05-20
US20090042853A1 (en) 2009-02-12
TNSN08537A1 (fr) 2010-04-14
NL2000715A1 (nl) 2008-01-02
WO2008001212A2 (en) 2008-01-03
MX2009000116A (es) 2009-01-23
JP2010013468A (ja) 2010-01-21
SV2008003139A (es) 2010-01-12
AU2007263519B2 (en) 2011-05-19
EA200870584A1 (ru) 2009-06-30
JP4397435B2 (ja) 2010-01-13
US7795244B2 (en) 2010-09-14
CR10467A (es) 2009-01-19
AR061646A1 (es) 2008-09-10
DE602007011622D1 (en) 2011-02-10
CA2655485C (en) 2011-08-02
EP2044085B1 (en) 2010-12-29
IL195383A0 (en) 2009-08-03
US7795243B2 (en) 2010-09-14
JP2009542616A (ja) 2009-12-03
EP2044085A2 (en) 2009-04-08
PE20080940A1 (es) 2008-07-09
AU2007263519A1 (en) 2008-01-03
KR20090015147A (ko) 2009-02-11
DK2044085T3 (da) 2011-03-07
JP5152527B2 (ja) 2013-02-27
BRPI0712740A2 (pt) 2012-06-05
KR101060448B1 (ko) 2011-08-29
WO2008001212A3 (en) 2008-03-20
CL2007001910A1 (es) 2008-01-11

Similar Documents

Publication Publication Date Title
NO20090392L (no) Penem promedikamenter
UA94749C2 (en) Benzimidazole modulators of vr1
NO20071078L (no) Antivirale forbindelser
NO20070866L (no) Antivirale forbindelser.
HRP20030383B1 (hr) Laktamski spoj
BRPI0510177B8 (pt) composto, composição farmacêutica e uso do mesmo
NO20081636L (no) FAP - inhibitorer
DE60230890D1 (de) Indolizine als kinaseproteinhemmer
SG10201809390QA (en) Modulators of indoleamine 2,3-dioxygenase and methods of using the same
CY1109911T1 (el) Πυρρολοβενζοδιαζεπινες
AU2002327180A1 (en) Detection and therapy of vulnerable plaque with photodynamic compounds
MXPA05008126A (es) Inhibidores de girasa y uso de los mismos.
NO20073764L (no) Sammensetninger for behandling av HCV
DK1682530T3 (da) Pyrrolsubstituerede indoler som inhibitorer af PAI-1
DK1789419T3 (da) Gyraseinhibitorer og anvendelser deraf
WO2008076427A3 (en) Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof
AU2007259257A8 (en) Antitumoral dihydropyran-2-one compounds
ATE472529T1 (de) Prolinamidderivate als natriumkanalmodulatoren
NO20075764L (no) Kombinert anvendelse av prostaglandinforbindelse og protonpumpeinhibitor til behandling av forstyrrelser i mage- og tarmkanalen
ATE375978T1 (de) Benzoylsulfonamide als antitumor-mittel
HRP20080529T3 (en) Amide prodrug of gemcitabine, compositions and use thereof
DK1373220T3 (da) Benzimidazoler, som er nyttige ved behandling af seksuel dysfunktion
TW200738281A (en) Bazedoxifene acetate formulations
ATE443044T1 (de) Tace inhibitoren
NO20054945L (no) Orale formulering av cladribin

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application